Influence of altitude exposure on coronary flow reserve

Circulation

Volumn 108, Issue 10, 2003, Pages 1202-1207

  Wyss, Christophe A ^a   Koepfli, Pascal ^a   Fretz, Gregory ^a   Seebauer, Magdalena ^b   Schirlo, Christian ^b   Kaufmann, Philipp A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Blood flow; Coronary disease; Exercise; Hypoxia; Tomography

Indexed keywords

ADENOSINE; OXYGEN 15;

ADULT; AGED; ALTITUDE; ARTICLE; BICYCLE ERGOMETRY; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; ELECTROCARDIOGRAM; EXERCISE; EXERCISE TEST; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; HYPEREMIA; HYPERVENTILATION; HYPOXIA; ISCHEMIC HEART DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WORKLOAD;

ADULT; AGED; ALTITUDE; ANOXIA; BLOOD FLOW VELOCITY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; EXERCISE TEST; EXERTION; HEART; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0041414400     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000087432.63671.2E     Document Type: Article

References (34)

1. Laciga P, Koller EA. Respiratory, circulatory, and ECG changes during acute exposure to high altitude. J Appl Physiol. 1976;41:159-167.
2. Volker K, Hoppe B, Krestin M, et al. Cross-country and downhill skiing in patients with myocardial infarct: can silent ischemia be prevented by drug therapy? Fortschr Med. 1990;108:273-275.
3. Alexander JK. Coronary problems associated with altitude and air travel. Cardiol Clin. 1995;13:271-278.
4. Beighton PH, Richards PR. Cardiovascular disease in air travellers. Br Heart J. 1968;30:367-372.
5. Manohar M, Parks CM, Busch MA, et al. Regional myocardial blood flow and coronary vascular reserve in unanesthetized young calves exposed to a simulated altitude of 3500 m for 8-10 weeks. Circ Res. 1982;50:714-726.
6. Reller MD, Morton MJ, Giraud GD, et al. Maximal myocardial blood flow is enhanced by chronic hypoxemia in late gestation fetal sheep. Am J Physiol. 1992;263:H1327-H1329.
7. Korner PI. Circulatory adaptations in hypoxia. Physiol Rev. 1959;39:687-730.
8. Katz LM, Feinberg H. The relation of cardiac effort to myocardial oxygen consumption and coronary flow. Circ Res. 1958;6:656-669.
9. Kaufmann PA, Schirlo C, Pavlicek V, et al. Increased myocardial blood flow during acute exposure to simulated altitudes. J Nucl Cardiol. 2001;8:158-164.
10. Diamond G, Forrester J. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med. 1979;300:1350-1358.
11. Cerqueira MD, Verain MS, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 1994;23:384-389.
12. Wyss CA, Koepfli P, Mikolajczyk K, et al. Reproducibility and comparison of coronary flow reserve assessed with PET using bicycle exercise versus adenosine stress. J Nucl Med. 2003;44:146-154.
13. Loeppky JA, Sotto P, Roach RC. Acute ventilatory response to simulated altitude, normobaric hypoxia and hypobaria. Aviat Space Environ Med. 1996;67:1019-1022.
14. 15O-labeled water and PET. J Nucl Med. 1999;40:1848-1856.
15. Uren NG, Melin JA, De BB, et al. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med. 1994;330:1782-1788.
16. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, et al. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation. 2000;102:1233-1238.
17. Kaufmann PA, Gnecchi-Ruscone T, Schäfers KP, et al. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol. 2000;36:103-109.
18. Kaijser L, Grubbstrom J, Berglund B. Coronary circulation in acute hypoxia. Clin Physiol. 1990;10:259-263.
19. Kaufmann P, Vassalli G, Utzinger U, et al, Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine. J Am Coll Cardiol. 1995;26:624-631.
20. Frielingsdorf J, Seiler C, Kaufmann P, et al. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension. Circulation. 1996;93:1380-1387.
21. Mandinov L, Kaufmann P, Staub D, et al. Coronary vasomotion after percutaneous transluminal coronary angioplasty depends on the severity of the culprit lesion. J Am Coll Cardiol. 1997;30:682-688.
22. Kaufmann PA, Frielingsdorf J, Mandinov L, et al. Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia. Circulation. 1998;97:1348-1354.
23. Gendreau MA, DeJohn C. Responding to medical events during commercial airline flights. N Engl J Med. 2002;346:1067-1073.
24. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2001;37:2215-2238.
25. Kaufmann P, Vassalli G, Utzinger U, et al. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine. J Am Coll Cardiol. 1995;26:624-631.
26. Kaufmann P, Mandinov L, Hess OM. Coronary stenosis vasoconstriction: impact on myocardial ischaemia. Eur Heart J. 1997;18:1853-1859.
27. Kaufmann P, Frielingsdorf J, Mandinov L, et al. Influence of the culprit lesion on clinical symptoms of coronary artery disease, with special emphasis on exercise data. Coron Artery Dis. 1998;9:185-190.
28. Meyers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801.
29. 13N-ammonia at rest and during exercise. Eur J Nucl Med. 1985;11:246-251.
30. Nienaber CA, Gambhir SS, Mody FV, et al. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation. 1993;87:1580-1590.
31. Muller P, Czernin J, Choi Y, et al. Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. Am Heart J. 1994;128:52-68.
32. Sauter J, Kopp KH. Veränderungen des Herz-Kreislaufsystems in der Höhe. Anästhesiol Intensivmed Notfallmed Schmerzther. 2001;36:299-301.
33. Veglio M, Maule S, Cametti G, et al. The effects of exposure to moderate altitude on cardiovascular autonomic function in normal subjects. Clin Autonom Res. 1999;9:123-127.
34. Chareonthaitawee P, Kaufmann PA, Rimoldi O, et al. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res. 2001;50:151-161.